Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service sleep apnea & airway implants cases in Ohio: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 15% on average (12 state-years, 2020–2024): small markets swing, so treat it as rough.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 1 | 25 | 47% |
| 2020 | 1 | 15 | 50% |
| 2021 | 1 | 15 | 56% |
| 2022 | 2 | 122 | 56% |
| 2023 | 4 | 214 | 58% |
| 2024 | 7 | 262 | 60% |
| 2025 from claims | – | 146 118–171 | 61% |
| 2026 forecast | – | 162 127–203 | 61% |
| 2027 forecast | – | 176 131–233 | 61% |
| 2028 forecast | – | 191 135–264 | 61% |
| 2029 forecast | – | 208 141–298 | 62% |
| 2030 forecast | – | 226 148–336 | 62% |
Hypoglossal nerve stimulation and upper airway procedures. Professional codes (what the surgeon bills): CPT 64582, 64583, 64584, 42145, 41530.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 100% of the cases CMS names in Ohio; 6 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 100% hospital outpatient.
| State | Surgeons | Medicare FFS | Growth since 2021 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Missouri | 11 | 224+173%/yr | +173%/yr | 0.3 | 0% | 150 in 2030−6.1%/yr |
| Illinois | 5 | 187+137%/yr | +137%/yr | 0.1 | 0% | 160 in 2030−2.3%/yr |
| Iowa | 6 | 171+55%/yr | +55%/yr | 0.4 | 36% | 140 in 2030−3.5%/yr |
| Indiana | 3 | 142+50%/yr | +50%/yr | 0.2 | 9% | 190 in 2030+4.8%/yr |
| Kansas | 5 | 135+70%/yr | +70%/yr | 0.3 | 0% | 140 in 2030+0.8%/yr |
| Nebraska | 2 | 105+149%/yr | +149%/yr | 0.4 | 19% | 90 in 2030−2.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 27 | 3,442−2.1%/yr | −2.1%/yr | 3.20.9× | 67% | 3,940 in 2030+2.3%/yr |
| Ear tubes & middle ear surgery | 5 | 613−2.7%/yr | −2.7%/yr | 0.61.9× | 24% | 470 in 2030−4.4%/yr |
| Cochlear implants | 4 | 209+11%/yr | +11%/yr | 0.21.0× | 0% | 320 in 2030+7.6%/yr |
Sleep apnea & airway implants in every state, and its device makers · Every procedure market in Ohio · Every state · Compare with Missouri
Inspire Medical Systems leads with 83% of company spending on these surgeons in 2025, −8 pts on 2024.
In 2025, 8 companies reported engagement with Ohio’s surgeons worth $206K in consulting, speaking, meals and travel tied to these products, about $29K per surgeon billing it. Royalties are left out.
FDA, last 12 months: 18 clearances and approvals in the category, 2 recalled product lines. A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.